Publications Office of the EU
Spain-Vitoria-Gasteiz: Pharmaceutical products - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Spain-Vitoria-Gasteiz: Pharmaceutical products

Overview
  • Awarded
    18/10/2017
  • Today
    20/10/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Osakidetza
Place of performance
NUTS code: ES51 Cataluña
Location of buyer
NUTS code: ES21 País Vasco
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
845,502.00
Total final contract value (excluding VAT)
845,502.00 EUR
Procedure details
Tender reference number
G/100/11/1/1265/OSC1/0000/062017
Description

Provision of laronidase (DOE) for Osakidetza Service Organisations.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
ES51 Cataluña
CPV code

33600000 - Pharmaceutical products

Award method
Lowest price
Estimated value
845,502.00
Final contracted value
845,502.00 EUR
Award of contract
Official name: Sanofi-Aventis, S.A.
Postal address:
Town: Barcelona
Postal code:
Country: ESP
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.